Charles Gordon, MD
Interventional Pain Medicine · Clifton Park, NYNPI 1649243890
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,355 of the $15,055 with a category attached, or 82.1%. Boston Scientific accounts for 73.3% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $5,042 and has fallen 65.7% since, to $1,729 in 2025.
Across 325 payments — averaging $46.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$11K
- Medtronic$1K
- Vertos Medical, Inc.$664
- Abbott$460
- SPR Therapeutics, Inc$414
- Nevro Corp.$340
- plus $1K from 12 others
What the payments were for
- Travel & lodging$2,70018%
- Food & beverage$12,35582%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 246 | $11,039 |
| Medtronic(2 entities) | 10 | $1,075 |
| Vertos Medical, Inc. | 11 | $664 |
| Abbott | 10 | $460 |
| SPR Therapeutics, Inc | 10 | $414 |
| Nevro Corp. | 10 | $340 |
| Nalu Medical, Inc. | 2 | $266 |
| Saluda Medical Americas, Inc. | 1 | $179 |
| Painteq LLC | 1 | $125 |
| Acelrx Pharmaceuticals, Inc. | 2 | $113 |
| Fidia Pharma USA Inc. | 6 | $105 |
| Pfizer | 6 | $83 |
| Si-bone, Inc. | 3 | $60 |
| Pacira Pharmaceuticals Incorporated | 1 | $50 |
| Relievant Medsystems, Inc. | 3 | $34 |
| Vertex | 1 | $20 |
| Foundation Fusion Solutions, LLC | 1 | $15 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$1,672
- WaveWriter Alpha Prime 16$1,601
- KYPHON EXPRESS II KYPHOPAK TRAY$791
- GENERAL PAIN MANAGEMENT$687
- Superion Indirect Decompression System$616
- mild Device Kit$355
- SPRINT PNS System$267
- Nalu Neurostimulation System$266
- Senza Spinal Cord Stimulation System$187
- Evoke$179
- Proclaim Family of SCS IPGs$140
- Octrode SCS Leads$126
- PAINTEQ$125
- WAVEWRITER ALPHA$124
- Intracept RF Probe$113
- Intracept$102
How this compares
$15,055 in reported general payments places this provider in the 80th percentile of 132 interventional pain medicine providers in New York.
See all interventional pain medicine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 11 | $272 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Clifton Park
- Corey HunterNew York$446K
- Neel MehtaNew York$432K
- Hemant KaliaRochester$179K
- Martin FerrilloAlbany$164K
- George ChaseKew Gardens$102K
- Kimberly SackheimNew York$102K
- Suelane OuroNew York$68K
- Gerard DegregorisNew York$49K
- Jafar SiddiquiWilliamsville$45K
- Alexander WeingartenSyosset$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.